InvestorsObserver
×
News Home

Can Neurometrix Inc (NURO) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, October 13, 2022 02:02 PM | InvestorsObserver Analysts

Mentioned in this article

Can Neurometrix Inc (NURO) Stock Rise to the Top of Healthcare Sector Thursday?

Neurometrix Inc (NURO) is around the bottom of the Healthcare sector according to InvestorsObserver. NURO received an overall rating of 39, which means that it scores higher than 39% of stocks. Additionally, Neurometrix Inc scored a 10 in the Healthcare sector, ranking it higher than 10% of stocks in that sector.

Overall Score - 39
NURO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on NURO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Neurometrix Inc Stock Today?

Neurometrix Inc (NURO) stock is lower by -1.84% while the S&P 500 has gained 2.39% as of 1:54 PM on Thursday, Oct 13. NURO is down -$0.04 from the previous closing price of $2.17 on volume of 192,559 shares. Over the past year the S&P 500 is down -16.07% while NURO is down -76.95%. NURO lost -$0.57 per share the over the last 12 months. Click Here to get the full Stock Report for Neurometrix Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App